Results 231 to 240 of about 12,489,625 (307)
When high hopes meet low action: identifying the "Ambitious Procrastinator" profile in the physical activity intention-behavior gap and its mental health toll. [PDF]
Liu X, Wei P.
europepmc +1 more source
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor +2 more
wiley +1 more source
Negative workplace gossip and organizational citizenship behavior in the Chinese kindergarten teaching workforce: exploring interpersonal trust as a mediator. [PDF]
Xu L, Feng B, Mao S.
europepmc +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
RETRACTED: Kim et al. Hair Cortisol and Fe-BARQ: Evaluating Chronic Stress and Behavior in Cats with Chronic Kidney Disease. <i>Animals</i> 2025, <i>15</i>, 889. [PDF]
Kim GH, Lee K, Choi HS, Han JS, Kim SA.
europepmc +1 more source
Molecular cancer prevention: Intercepting disease
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco +2 more
wiley +1 more source
The relationship between in-group favoritism and online prosocial behaviors among college students: the role of moral self and the belief in a just world. [PDF]
Zhang K, Chen C, Sang Q.
europepmc +1 more source
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source

